A health system in the area has hired three new physicians for its oncology department.
Metro Health-University of Michigan Health added Dr. Kevin Brader, Dr. Sulsal Haque and Dr. Ahmet Tunceroglu, according to the system last month.
“Cancer touches so many lives in West Michigan,” said Laura Smith, director of Oncology Services, Metro Health. “These additions help us fulfill our commitment to stand alongside our patients, whatever they are going through, by growing capabilities and expertise where our patients need it.”
Brader is a gynecologic oncologist with more than a decade of experience in robotic surgery to treat women experiencing cancer of the reproductive organs.
Brader’s medical degree is from Northwestern University Medical School. He completed his residency in obstetrics and gynecology at the Northwestern University Feinberg School of Medicine and a fellowship in gynecologic oncology at the University of Texas MD Anderson Cancer Center.
He is board certified in gynecologic oncology.
Sulsal Haque is a medical oncologist specializing in the diagnosis and treatment of oncologic malignancies, as well as benign and malignant hematologic disorders.
Haque’s medical degree comes from Leicester Warwick Medical Schools. He completed a residency in internal medicine at University of Cincinnati Medical Center, where he also completed a fellowship in hematology/oncology.
He is board certified in internal medicine.
Ahmet Tunceroglu specializes in radiation oncology or the use of ionizing radiation in the treatment of cancer.
He has a medical degree from the University of Medicine and Dentistry of New Jersey, where he also earned a doctorate in biomedical sciences. He completed his residency at the Rutgers University Robert Wood Johnson Medical School.
He is board eligible in radiation oncology.